Xiaoling Fang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Xiaoling Fang has a total of 21 co-authors. Here are the top co-authors by number of shared publications:
- Qi Wang
Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China; Institute of Clinical Pharmacology, Guangzhou University of Chinese Medicine, Guangzhou, 510405, China
3 shared publications - Guangcheng Zhong
Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China
2 shared publications - Shuiqing Huang
Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China
2 shared publications - Xinyue Wang
Department of Oncology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China; Guangdong Provincial Key Laboratory of Colorectal and Pelvic Floor Disease, Guangdong Research Institute of Gastroenterology, The Sixth Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510655, China
2 shared publications Yaru Pan
Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China
2 shared publications- Yujie Ma
Science and Technology Innovation Center, Guangzhou University of Chinese Medicine, Guangzhou, China
2 shared publications
Latest Publications
- 2 May 2025
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1001, 177649
The role of copper homeostasis and cuproptosis in cerebrovascular diseases:A novel therapeutic target
- 2 May 2025
- Published by Elsevier in European Journal of Pharmacology
- Vol. 1001, 177649
The role of copper homeostasis and cuproptosis in cerebrovascular diseases:A novel therapeutic target
- 2 September 2024
- Published by Wiley in Phytotherapy Research
- Vol. 38 (11) , 5270-5289
Exploring the therapeutic implications of natural compounds modulating apoptosis in vascular dementia
Vascular dementia (VaD) is a prevalent form of dementia stemming from cerebrovascular disease, manifesting in memory impairment and executive dysfunction, thereby imposing a substantial societal burden. Unfortunately, no drugs have been approved for the treatment of VaD due to its intricate pathogenesis, and the development of innovative and efficacious medications is urgently needed. Apoptosis, a programmed cell death process crucial for eliminating damaged or unwanted cells within an organism, assumes pivotal roles in embryonic development and tissue homeostasis maintenance. An increasing body of evidence indicates that apoptosis may significantly influence the onset and progression of VaD, and numerous natural compounds have demonstrated significant therapeutic potential. Here, we discuss the molecular mechanisms underlying apoptosis and its correlation with VaD. We also provide a crucial reference for developing innovative pharmaceuticals by systematically reviewing the latest research progress concerning the neuroprotective effects of natural compounds on VaD by regulating apoptosis. Further high‐quality clinical studies are imperative to firmly ascertain these natural compounds' clinical efficacy and safety profiles in the treatment of VaD.
- 2 September 2024
- Published by Wiley in Phytotherapy Research
- Vol. 38 (11) , 5270-5289
Exploring the therapeutic implications of natural compounds modulating apoptosis in vascular dementia
Vascular dementia (VaD) is a prevalent form of dementia stemming from cerebrovascular disease, manifesting in memory impairment and executive dysfunction, thereby imposing a substantial societal burden. Unfortunately, no drugs have been approved for the treatment of VaD due to its intricate pathogenesis, and the development of innovative and efficacious medications is urgently needed. Apoptosis, a programmed cell death process crucial for eliminating damaged or unwanted cells within an organism, assumes pivotal roles in embryonic development and tissue homeostasis maintenance. An increasing body of evidence indicates that apoptosis may significantly influence the onset and progression of VaD, and numerous natural compounds have demonstrated significant therapeutic potential. Here, we discuss the molecular mechanisms underlying apoptosis and its correlation with VaD. We also provide a crucial reference for developing innovative pharmaceuticals by systematically reviewing the latest research progress concerning the neuroprotective effects of natural compounds on VaD by regulating apoptosis. Further high‐quality clinical studies are imperative to firmly ascertain these natural compounds' clinical efficacy and safety profiles in the treatment of VaD.
- 14 February 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (9) , 6864-6892
Exosomes: A Cellular Communication Medium That Has Multiple Effects On Brain Diseases
Exosomes, as membranous vesicles generated by multiple cell types and secreted to extracellular space, play a crucial role in a range of brain injury–related brain disorders by transporting diverse proteins, RNA, DNA fragments, and other functional substances. The nervous system’s pathogenic mechanisms are complicated, involving pathological processes like as inflammation, apoptosis, oxidative stress, and autophagy, all of which result in blood-brain barrier damage, cognitive impairment, and even loss of normal motor function. Exosomes have been linked to the incidence and progression of brain disorders in recent research. As a result, a thorough knowledge of the interaction between exosomes and brain diseases may lead to the development of more effective therapeutic techniques that may be implemented in the clinic. The potential role of exosomes in brain diseases and the crosstalk between exosomes and other pathogenic processes were discussed in this paper. Simultaneously, we noted the delicate events in which exosomes as a media allow the brain to communicate with other tissues and organs in physiology and disease, and compiled a list of natural compounds that modulate exosomes, in order to further improve our understanding of exosomes and propose new ideas for treating brain disorders.
- 14 February 2024
- Published by Springer Nature in Molecular Neurobiology
- Vol. 61 (9) , 6864-6892
Exosomes: A Cellular Communication Medium That Has Multiple Effects On Brain Diseases
Exosomes, as membranous vesicles generated by multiple cell types and secreted to extracellular space, play a crucial role in a range of brain injury–related brain disorders by transporting diverse proteins, RNA, DNA fragments, and other functional substances. The nervous system’s pathogenic mechanisms are complicated, involving pathological processes like as inflammation, apoptosis, oxidative stress, and autophagy, all of which result in blood-brain barrier damage, cognitive impairment, and even loss of normal motor function. Exosomes have been linked to the incidence and progression of brain disorders in recent research. As a result, a thorough knowledge of the interaction between exosomes and brain diseases may lead to the development of more effective therapeutic techniques that may be implemented in the clinic. The potential role of exosomes in brain diseases and the crosstalk between exosomes and other pathogenic processes were discussed in this paper. Simultaneously, we noted the delicate events in which exosomes as a media allow the brain to communicate with other tissues and organs in physiology and disease, and compiled a list of natural compounds that modulate exosomes, in order to further improve our understanding of exosomes and propose new ideas for treating brain disorders.